Ascentage Pharma Group International (AAPG) Institutional Ownership

Ownership Summary

The institutional landscape for Ascentage Pharma Group International (NASDAQ:AAPG) includes 2 filers as of the latest reporting cycle ending December 2025.

• The collective stake of institutional investors in Ascentage Pharma Group International moved to 0.1% in December 2025, a shift down from the 0.8% reported for September 2025.
• In percentage terms, this reflects as a holdings change of -67.43% quarter on quarter, and an unavailable change year over year.
• Among the 2 institutional holders of Ascentage Pharma Group International, 1 added to their stakes while 1 trimmed their positions and 0 held steady.
• This class of investors decreased its holdings in Ascentage Pharma Group International to 6.78K shares for the 13F-cycle ending December 2025, down by 14.03K shares quarter on quarter, and down N/A shares year over year.
• UBS Group AG continues to be the largest institutional holder of Ascentage Pharma Group International as of December 31, 2025, with a position of 4.23K shares, representing 0.04% of the company's outstanding stock.
• Among the most significant buyers of Ascentage Pharma Group International during December 2025 were Mirae Asset Global Investments Co., Ltd. (83).
• Leading sellers of Ascentage Pharma Group International stock in December 2025 included UBS Group AG (14.11K).
• The top 2 institutional holders of Ascentage Pharma Group International for the quarter ending December 2025 included UBS Group AG (4.23K), Mirae Asset Global Investments Co., Ltd. (2.55K).